Brian M Wolpin Selected Research

ABO Blood-Group System

5/2012	ABO blood group and breast cancer incidence and survival.
5/2011	ABO blood group and risk of colorectal cancer.
1/2011	ABO blood group and incidence of epithelial ovarian cancer.
12/2010	Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.
2/2010	Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
3/2009	ABO blood group and the risk of pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian M Wolpin Research Topics

Disease

56	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 08/2007
52	Neoplasms (Cancer) 10/2022 - 05/2007
22	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2006
18	Adenocarcinoma 01/2022 - 06/2014
8	Carcinogenesis 10/2021 - 07/2008
5	Disease Progression 01/2022 - 12/2008
5	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2007
4	Inflammation (Inflammations) 10/2022 - 05/2013
4	Obesity 01/2020 - 12/2016
3	Diarrhea 10/2020 - 09/2006
3	Microsatellite Instability 01/2019 - 06/2009
3	Insulin Resistance 07/2013 - 09/2011
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2022 - 10/2021
2	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2017
2	Margins of Excision 01/2022 - 12/2017
2	Melanoma (Melanoma, Malignant) 07/2021 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 06/2019 - 05/2012
2	Neutropenia 01/2019 - 09/2006
2	Carcinoma (Carcinomatosis) 10/2017 - 01/2017
2	Hyperinsulinism (Hyperinsulinemia) 09/2017 - 09/2011
2	Ovarian Neoplasms (Ovarian Cancer) 09/2016 - 01/2011
2	Fibrosis (Cirrhosis) 02/2015 - 03/2011
2	Hyperglycemia 07/2013 - 01/2009
2	Overweight 09/2011 - 05/2010
1	Gallstones (Gallstone) 10/2022
1	Liver Neoplasms (Liver Cancer) 10/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Iron Overload 10/2021
1	Hemochromatosis (Bronze Diabetes) 10/2021

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
9	Insulin (Novolin)FDA Link 01/2020 - 08/2007
6	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 09/2006
6	ABO Blood-Group SystemIBA 05/2012 - 03/2009
5	Leucovorin (Folinic Acid)FDA Link 01/2022 - 09/2006
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 05/2007
5	Pharmaceutical PreparationsIBA 12/2021 - 02/2014
5	EnzymesIBA 07/2021 - 01/2012
5	hydroxide ionIBA 11/2020 - 01/2012
5	25-hydroxyvitamin DIBA 11/2020 - 01/2012
5	C-PeptideIBA 12/2016 - 08/2007
5	Irinotecan (Camptosar)FDA LinkGeneric 08/2015 - 09/2006
4	ORALIT (ORS)IBA 01/2022 - 02/2010
4	Proteins (Proteins, Gene)FDA Link 10/2021 - 10/2014
4	Biological ProductsIBA 01/2021 - 07/2012
4	Vitamin D FDA LinkGeneric 11/2020 - 01/2012
4	ErbB Receptors (EGF Receptor)IBA 06/2019 - 09/2006
4	Blood Group Antigens (Blood Groups)IBA 05/2011 - 03/2009
3	LipidsIBA 11/2021 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 05/2012
3	Gemcitabine FDA Link 01/2020 - 01/2009
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2018 - 10/2017
3	Branched-Chain Amino AcidsIBA 10/2016 - 10/2014
3	Cetuximab (Erbitux)FDA Link 02/2014 - 01/2012
3	Everolimus FDA Link 01/2013 - 01/2009
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2009 - 08/2007
3	Insulin-Like PeptidesIBA 01/2009 - 08/2007
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 01/2019
2	PlatinumIBA 12/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 10/2021 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 05/2013
2	C-Reactive ProteinIBA 01/2021 - 05/2013
2	STA 9090IBA 10/2020 - 02/2015
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 08/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2018
2	NitrogenIBA 01/2017 - 01/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2017 - 11/2015
2	AdiponectinIBA 12/2016 - 01/2013
2	Monoclonal AntibodiesIBA 02/2014 - 01/2012
2	Folic Acid (Vitamin M)FDA LinkGeneric 03/2013 - 07/2008
2	beta CateninIBA 08/2009 - 06/2009
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 08/2009 - 06/2009
2	Cyclin D1IBA 08/2009 - 06/2009
2	Insulin-Like Growth Factor Binding Protein 1IBA 01/2009 - 08/2007
2	Insulin-Like Growth Factor Binding Protein 3IBA 01/2009 - 12/2008
2	Gefitinib (Iressa)FDA Link 05/2007 - 09/2006
1	Hormones (Hormone)IBA 10/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 12/2021
1	olaparibIBA 12/2021
1	Monounsaturated Fatty AcidsIBA 11/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2021
1	Stearoyl-CoA DesaturaseIBA 11/2021
1	P-2 (P 2)IBA 10/2021
1	ChymotrypsinogenIBA 10/2021
1	Chymotrypsin FDA Link 10/2021
1	IronIBA 10/2021

Therapy/Procedure

19	Therapeutics 12/2021 - 09/2006
15	Drug Therapy (Chemotherapy) 01/2022 - 05/2007
6	Adjuvant Chemotherapy 01/2022 - 05/2007
3	Neoadjuvant Therapy 01/2022 - 11/2017
3	Radiotherapy 01/2022 - 05/2007
2	Pancreatectomy 01/2022 - 12/2017
2	Immunotherapy 01/2021 - 01/2021
2	Precision Medicine 01/2018 - 01/2018
2	Combination Drug Therapy (Combination Chemotherapy) 06/2012 - 05/2007
1	Cholecystectomy 10/2022
1	Pancreaticoduodenectomy 01/2022
1	Length of Stay 01/2022